NSEAnalysts/Institutional Investor Meet/Con. Call Updates9 Sept 2026 · 9 Sept 2026, 07:30 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Fortis Healthcare Limited · FORTIS
✦ AI Summary
Fortis Healthcare Limited has informed the Exchange about the schedule of upcoming Investor Meetings with the Management to discuss general business update and industry operations.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Fortis Healthcare Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
FORTIS_09092026192946_intimation.pdf
View document text
Fortis Healthcare Limited
Tower-A, Unitech Business Park, Block-F,
South City 1, Sector – 41, Gurgaon,
Haryana – 122 001 (India)
Tel : 0124 492 1033
Fax : 0124 492 1041
Emergency : 105010
Email : secretarial@fortishealthcare.com
Website : www.fortishealthcare.com
September 9, 2026
FHL/SEC/2026-27
The National Stock Exchange of India Ltd. BSE Limited
Scrip Symbol: FORTIS Scrip Code:532843
Sub: Intimation of schedule of Investors / Analysts’ meet under Regulation 30 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015.
Dear Madam/Sir,
In compliance of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, please find below the schedule of upcoming Investor Meetings with the Management
of Fortis Healthcare Limited (“FHL”), to discuss about the general business update and the industry, in
which the Company operates:
Sr. Date & Time Investors / Analysts / Mode of Type of Location
No Events Meeting Meeting
1 Date: 14th Non Deal Road show London
September 2026 and (Organized by Jefferies) One-on-One
15th September 2026 In-person and Group Meet
Time: 8 AM to 5 PM
BST/12.30 PM to
9.30 PM IST
Please note that the above schedule and timings are subject to changes due to exigencies on the part of the
Investors/Company.
No Unpublished Price Sensitive Information (UPSI) shall be shared / discussed at the investor meet.
This is for your kind information and records.
Thanking you,
Yours Sincerely,
For Fortis Healthcare Limited
Satyendra Chauhan
Company Secretary & Compliance Officer
ICSI Membership: A14783
FORTIS HEALTHCARE LIMITED
Regd. Office : Fortis Hospital, Sector 62, Phase – VIII, Mohali – 160062
Tel : 0172-4692222, Fax : 0172-5096221, CIN : L85110PB1996PLC045933